These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21964323)

  • 1. JNK inhibitors increase osteogenesis in Nf1-deficient cells.
    Sullivan K; El-Hoss J; Little DG; Schindeler A
    Bone; 2011 Dec; 49(6):1311-6. PubMed ID: 21964323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells.
    El-Hoss J; Sullivan K; Cheng T; Yu NY; Bobyn JD; Peacock L; Mikulec K; Baldock P; Alexander IE; Schindeler A; Little DG
    J Bone Miner Res; 2012 Jan; 27(1):68-78. PubMed ID: 21956219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis.
    El-Hoss J; Cheng T; Carpenter EC; Sullivan K; Deo N; Mikulec K; Little DG; Schindeler A
    J Bone Joint Surg Am; 2014 Jul; 96(14):e117. PubMed ID: 25031379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation.
    Guicheux J; Lemonnier J; Ghayor C; Suzuki A; Palmer G; Caverzasio J
    J Bone Miner Res; 2003 Nov; 18(11):2060-8. PubMed ID: 14606520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.
    de la Croix Ndong J; Stevens DM; Vignaux G; Uppuganti S; Perrien DS; Yang X; Nyman JS; Harth E; Elefteriou F
    J Bone Miner Res; 2015 Jan; 30(1):55-63. PubMed ID: 25043591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.
    Sharma R; Wu X; Rhodes SD; Chen S; He Y; Yuan J; Li J; Yang X; Li X; Jiang L; Kim ET; Stevenson DA; Viskochil D; Xu M; Yang FC
    Hum Mol Genet; 2013 Dec; 22(23):4818-28. PubMed ID: 23863460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation.
    Fromigué O; Marie PJ; Lomri A
    J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation.
    Song L; Zhao J; Zhang X; Li H; Zhou Y
    Eur J Pharmacol; 2013 Aug; 714(1-3):15-22. PubMed ID: 23764463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wedelolactone Enhances Osteoblastogenesis through ERK- and JNK-mediated BMP2 Expression and Smad/1/5/8 Phosphorylation.
    Zhu D; Deng X; Han XF; Sun XX; Pan TW; Zheng LP; Liu YQ
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice.
    Schindeler A; Ramachandran M; Godfrey C; Morse A; McDonald M; Mikulec K; Little DG
    J Orthop Res; 2008 Jan; 26(1):65-74. PubMed ID: 17787010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose- and time-dependent effects of recombinant human bone morphogenetic protein-2 on the osteogenic and adipogenic potentials of alveolar bone-derived stromal cells.
    Park JC; Kim JC; Kim BK; Cho KS; Im GI; Kim BS; Kim CS
    J Periodontal Res; 2012 Oct; 47(5):645-54. PubMed ID: 22471302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M-Ras is activated by bone morphogenetic protein-2 and participates in osteoblastic determination, differentiation, and transdifferentiation.
    Watanabe-Takano H; Takano K; Keduka E; Endo T
    Exp Cell Res; 2010 Feb; 316(3):477-90. PubMed ID: 19800879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human serine protease HTRA1 positively regulates osteogenesis of human bone marrow-derived mesenchymal stem cells and mineralization of differentiating bone-forming cells through the modulation of extracellular matrix protein.
    Tiaden AN; Breiden M; Mirsaidi A; Weber FA; Bahrenberg G; Glanz S; Cinelli P; Ehrmann M; Richards PJ
    Stem Cells; 2012 Oct; 30(10):2271-82. PubMed ID: 22865667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of growth and osteogenic differentiation of rabbit bone marrow stromal cells.
    Roostaeian J; Carlsen B; Simhaee D; Jarrahy R; Huang W; Ishida K; Rudkin GH; Yamaguchi DT; Miller TA
    J Surg Res; 2006 Jun; 133(2):76-83. PubMed ID: 16360178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro.
    Puleo DA
    J Cell Physiol; 1997 Oct; 173(1):93-101. PubMed ID: 9326453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta mouse (oim).
    Balk ML; Bray J; Day C; Epperly M; Greenberger J; Evans CH; Niyibizi C
    Bone; 1997 Jul; 21(1):7-15. PubMed ID: 9213002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.
    Wang W; Nyman JS; Ono K; Stevenson DA; Yang X; Elefteriou F
    Hum Mol Genet; 2011 Oct; 20(20):3910-24. PubMed ID: 21757497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.
    Cowan CM; Jiang X; Hsu T; Soo C; Zhang B; Wang JZ; Kuroda S; Wu B; Zhang Z; Zhang X; Ting K
    J Bone Miner Res; 2007 Jun; 22(6):918-30. PubMed ID: 17352654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockage by SP600125 of Fcepsilon receptor-induced degranulation and cytokine gene expression in mast cells is mediated through inhibition of phosphatidylinositol 3-kinase signalling pathway.
    Tanemura S; Momose H; Shimizu N; Kitagawa D; Seo J; Yamasaki T; Nakagawa K; Kajiho H; Penninger JM; Katada T; Nishina H
    J Biochem; 2009 Mar; 145(3):345-54. PubMed ID: 19106158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.